All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Completed, but no date, and reported results | 2004-000414-39 | A randomised, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the long-term efficacy and safety of Norspan® versus placebo Norspan in subjects with chronic, moderate to... | bad-data | |
| Reported results | 2004-003752-19 | A Randomized, Double-blind, Placebo- and Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged-release Tablets in Subjects with Mod... | 2007-07-23 | due-trials |
| Reported results Terminated | 2005-001791-13 | An open-label, randomized, parallel-group, monocenter study to evaluate safety and efficacy of Oxycodone Hydrochloride administered orally (CR) and intravenously in patients with total hip endoprosthe... | 2007-07-03 | due-trials |
| Reported results | 2005-002398-57 | A randomized, double-blind, parallel-group, multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of lt; 20 mg/day ... | 2008-04-25 | due-trials |
| Reported results | 2005-003510-15 | A randomised, double-blind, double-dummy, parallel-group multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of 60 ... | 2008-07-14 | due-trials |
| Reported results | 2006-001888-40 | A phase II prospective non-comparative multicenter clinical trial to determine the efficacy and safety of intrathecal liposomal cytarabine (DepoCyte®) in preventing CNS-relapse in patients with aggres... | 2008-02-01 | due-trials |
| Reported results | 2006-003233-32 | A randomized, open, controlled parallel group, multi-center study to evaluate the efficacy and safety of Norspan versus Tiparol Retard in subjects with chronic, moderate to severe osteoarthritis pain ... | 2007-08-30 | due-trials |
| Reported results | 2006-005926-22 | An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiForm pMDI vs Seretide pMDI in adult subjects with mild to moderate-severe persistent, reversible asthm... | 2008-03-13 | due-trials |
| Reported results | 2006-005928-16 | An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiForm pMDI vs Seretide pMDI in paediatric subjects with mild to moderate persistent, reversible asthma. | 2008-06-27 | due-trials |
| Ongoing | 2007-000179-41 | Intrathecal chemotherapy with liposomal ara-C (Depocyte) in leptomeningeal metastases of solid tumors: a phase III study | not-yet-due | |
| Reported results | 2007-001313-42 | A randomised, double-blind, active-controlled, double-dummy, parallel group study to determine the safety and efficacy of oxycodone / naloxone prolonged release tablets in subjects with moderate to se... | 2010-08-17 | due-trials |
| Reported results | 2007-001633-34 | A double blind, double dummy, randomised, multicentre, four arm parallel group study to assess the efficacy and safety of FlutiForm™ pMDI 250/10 µg (2 puffs bid) vs Fluticasone pMDI 250 µg (2 puffs bi... | 2009-08-27 | due-trials |
| Reported results | 2007-001634-13 | An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiFormTM pMDI compared with Fluticasone pMDI plus Formoterol DPI in adolescent and adult subjects with m... | 2008-04-01 | due-trials |
| Reported results | 2007-005101-21 | An open, multi-centre, non-comparative observational study to assess the safety and tolerability of Oxycodone hydrochloride injection 50 mg/mL as a subcutaneous infusion in subjects with severe cancer... | 2009-05-29 | due-trials |
| Reported results | 2007-005922-62 | An exploratory, randomised, active-controlled, double-blind, double-dummy, parallel group pilot study to determine the ability of oxycodone/naloxone prolonged release tablets (OXN) to reduce the numbe... | 2008-12-26 | due-trials |
| Reported results | 2008-001026-14 | An open study with OXN to evaluate the patient preference for pain treatment with respect to quality of life after WHO step I or step II analgesics for patients with moderate to severe non-malignant p... | 2012-01-23 | due-trials |
| Reported results | 2008-002185-60 | RANDOMISED, CONTROLLED CLINICAL STUDY REGARDING THE FEASIBILITY OF CONVERTING OPIATE DEPENDENTS FROM METHADONE SUBSTITUTES TO SLOW RELEASE MORPHINE SULPHATE (SEVRE-LONG®) | 2011-06-29 | due-trials |
| Exempt, with results | 2008-002219-42 | A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children with Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non-Hodgkins Lymphom... | 2010-10-14 | not-yet-due |
| Exempt, with results Terminated | 2008-002428-27 | A multi-centre, open-label, single therapy, dose ranging study to characterise the pharmacokinetics and tolerability of BTDS 5-20 µg/h in children who require opioid analgesia for moderate to severe m... | 2012-11-22 | not-yet-due |
| Reported results | 2008-002670-36 | A randomised, double-blind, double-dummy, parallel-group multicentre study to demonstrate non-inferiority in pain and locomotor function and improvement in symptoms of constipation in subjects with mo... | 2010-08-02 | due-trials |
| Reported results | 2008-003566-26 | An exploratory, randomised, parallel-group, open-label, multicentre study to assess the post-operative management of moderate to severe pain in patients who underwent laparoscopic cholecystectomy, rec... | 2009-03-13 | due-trials |
| Reported results | 2008-005315-18 | A confirmatory, placebo-controlled, randomised, double-blind, single-dummy, parallel group, ratio-finding study in constipated pain patients to establish an optimal hydromorphone – naloxone ratio with... | 2012-01-12 | due-trials |
| Reported results | 2008-005815-17 | An exploratory, randomised, double-blind, single-dummy, placebo controlled, parallel group study to demonstrate the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) in addit... | 2010-04-02 | due-trials |
| Reported results | 2009-009873-87 | A double-blind, randomised, incomplete block, crossover, placebo-controlled, dose-response study to assess bronchial hyperresponsiveness and airway inflammation effects of FlutiForm® pMDI low and high... | 2010-07-14 | due-trials |
| Reported results | 2009-011107-23 | A randomised, double-blind, placebo-controlled, parallel-group, multicenter study to demonstrate improvement of symptoms of RLS in subjects with moderate to severe idiopathic RLS with daytime symptoms... | 2012-04-24 | due-trials |
| Reported results | 2009-012051-20 | Study of the efficacy of prolonged release oxycodone/naloxone (OXN PR), compared to prolonged release oxycodone (Oxy PR), for the reduction of the intensity of opioid-induced constipation symptoms in ... | 2011-06-28 | due-trials |
| Reported results | 2009-016957-17 | A randomised, double-blind, parallel group multicenter study to demonstrate non-inferiority of the analgesic efficacy of oxycodone/naloxone 10/5 or 20/10 mg prolonged release tablets (OXN PR) BID comp... | 2010-10-17 | due-trials |
| Reported results | 2009-017223-25 | A double blind, double dummy, randomised, multicentre, two arm parallel group study to assess the efficacy and safety of FlutiForm® pMDI 125/5 µg (2 puffs bid) vs Symbicort® Turbohaler® 200/6 µg (2 pu... | 2010-11-15 | due-trials |
| Reported results | 2009-018118-21 | An exploratory, randomised, double-blind, placebo-controlled, parallel group, pilot study to assess the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) compared to placebo ... | 2013-03-25 | due-trials |
| Reported results | 2010-020748-37 | An open label, multi-centre, prospective age-group-controlled study to evaluate efficacy and safety of buprenorphine transdermal patches in subjects with chronic, moderate to severe osteoarthritis pai... | 2012-08-20 | due-trials |
| Reported results | 2010-021995-27 | A randomised, double-blind, double-dummy, parallel-group multicenter study to demonstrate improvement in symptoms of constipation and noninferiority in analgesic efficacy in subjects with non-malignan... | 2014-08-18 | due-trials |
| Reported results | 2010-022102-41 | A randomised, open label, multi-centre, Phase III study to investigate the efficacy of bendamustine compared to treatment of physician's choice in the treatment of subjects with indolent Non-Hodgkin's... | 2018-07-31 | due-trials |
| Reported results | 2010-024635-16 | A double-blind, double dummy randomised, parallel group, multicentre study to compare the efficacy and safety of Flutiform pMDI with fluticasone pMDI and with Seretide pMDI in paediatric subjects aged... | 2013-09-19 | due-trials |
| Reported results | 2011-000939-86 | An open-label single site single dose pilotstudy using mannitol challenge test with the purpose to explore treatment with fixed dose combinations in adult subjects with asthma in primary care in Swede... | 2012-04-17 | due-trials |
| Reported results | 2011-002353-57 | A randomised, multi-centre, double-blind, active-controlled, parallel group study to assess the efficacy and safety of modified release prednisone (Lodotra®) compared to immediate release prednisone (... | 2014-03-25 | due-trials |
| Reported results | 2011-002901-31 | A multicentre, double-blind, randomised, placebo controlled study to determine the efficacy and tolerability of OXN PR for the treatment of severe Parkinson's disease associated pain | 2013-11-05 | due-trials |
| Reported results | 2012-001772-11 | An exploratory, double-blind, double-dummy, randomised, 2-period, crossover, Phase IIa study to assess the influence of oxycodone/naloxone prolonged-release tablets (OXN PR) and oxycodone prolonged-re... | 2015-02-17 | due-trials |
| Reported results | 2012-004162-17 | A randomised, double-blind, double dummy, parallel group study comparing Fluticasone propionate / formoterol fumarate (flutiform®) 250/10 mcg (2 puffs BID) and flutiform® 125/5 mcg (2 puffs BID) versu... | 2016-05-04 | due-trials |
| Reported results | 2013-000180-81 | A single-arm, open-label, multicentre, non-randomised, study to assess the effect and tolerability of standardised laxative therapy (SLT) for the reversal of opioid-induced constipation (OIC) in subj... | 2014-08-27 | due-trials |
| Reported results | 2013-004719-32 | A single (assessor) - blind, randomised, three-period, cross-over study to compare the safety of flutiform® pMDI, fluticasone pMDI and beclometasone Autohaler® in paediatric subjects aged 5 to less ... | 2014-06-11 | due-trials |
| Reported results | 2013-004888-31 | A randomised, double-blind, double-dummy, cross-over multicenter study to demonstrate equivalence in analgesic efficacy and bowel function taking oxycodone equivalents of 120 and 160 mg per day as ach... | 2016-08-03 | due-trials |
| Reported results | 2014-004564-38 | A randomised, open label, two-period, cross-over, multi-centre study to compare correct inhaler handling of fluticasone/ formoterol breath-actuated inhaler (K-haler®) with that of Symbicort® Turbohale... | 2017-07-04 | due-trials |
| Ongoing | 2014-004904-31 | An open-label, multicentre, phase IV study to investigate the infliximab serum concentration of Remsima™ (infliximab biosimilar) after switching from Remicade (infliximab) in subjects with Crohn’s Dis... | not-yet-due | |
| Reported results | 2015-000801-38 | A two-arm, randomised, assessor-blind, parallel group study to evaluate the effect of fluticasone/formoterol breath actuated inhaler (BAI) and Relvar Ellipta DPI on ventilation heterogeneity in subjec... | 2017-08-14 | due-trials |
| Not reported | 2015-002046-31 | A randomised, single blind, cross-over study to compare a fixed dose combination of fluticasone propionate / formoterol fumarate (fluticasone /formoterol breath actuated inhaler (BAI)) with a fixed d... | 2016-11-07 | due-trials |
| Reported results | 2016-000592-24 | A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Third Molar Tooth Extraction (STA... | 2018-01-04 | due-trials |
| Reported results | 2016-000593-38 | A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Abdominal Hysterectomy Surgery un... | 2018-06-29 | due-trials |
| Not reported | 2017-000338-70 | A phase IIIb open randomized clinical trial to compare pain relief between methoxyflurane and standard of care for treating patients with trauma pain in Spanish emergency units. Ensayo clínico fase... | 2018-04-02 | due-trials |
| Completed, but no date | 2017-001565-25 | Efficacy and safety of methoxyflurane vaporized (PENTHROX®) in the treatment of acute trauma pain in pre-hospital setting and in the emergency department in Italy: a multicentre, randomized, controlle... | bad-data | |
| Reported results | 2017-003767-35 | A randomised, double-blind, parallel group study comparing patient controlled analgesia with Penthrox® (methoxyflurane) versus placebo during colonoscopy | 2018-07-12 | due-trials |
| Ongoing | 2017-004469-28 | Multicentre, randomised, double-blind study assessing the efficacy and safety of Penthrox® combined with a standard analgesia (SoC) in comparison to a placebo combined with a standard analgesia (SoC) ... | not-yet-due | |
| Completed, but no date | 2017-004601-40 | Efficacy and safety of methoxyflurane in helicopter emergency medical system and hostile environment: a prospective, multicentre clinical trial Studio clinico prospettico, multicentrico di valutazi... | bad-data | |
| Not reported Terminated | 2018-001601-82 | Open randomized clinical trial to compare pain relief between low-dose methoxyflurane and standard of care for the treatment of patients with trauma pain in emergency medical services in the Netherlan... | 2020-06-29 | due-trials |
| Completed, but no date Terminated | 2020-000302-28 | Open randomized low interventional clinical trial to compare efficiency in symptom control between fluticasone propionate/formoterol k-haler at medium strength versus an high strength ICS/LABA for the... | bad-data | |
| Reported results | 2020-004246-11 | A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics and Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition (HDACi) Fusion Molecule, in Patients with Advan... | 2023-03-29 | due-trials |